(Q77918632)
Statements
Treatment with high dose [(111)In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors--evaluation of therapeutic and toxic effects (English)
E Tiensuu Janson
B Eriksson
K Oberg
B Skogseid
U Ohrvall
S Nilsson
1 January 1999